US Patent 11802154 Humanized anti-CD200 antibodies and uses thereof
Patent 11802154 was granted and assigned to Alexion Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11802154 Humanized anti-CD200 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
